correlation between the efficiency of C-H insertion and the
nature of the C-H bond undergoing reaction is likely a
reflection of the highly reactive, undiscriminating nature of
the alkylidenecarbene intermediates generated during this
reaction. Having established the viability of this methodol-
ogy, we turned our attention to its application to natural
product synthesis.
Scheme 4
The dried and pulverized flower buds of Magnolia
fargessi, also known as “shin-i”, have been used for centuries
in China and Japan as materia medica. While traditionally
this material has been indicated for the relief of nasal
congestion and headaches, more recently it has proven to
be a rich source of natural products, including several
biologically active lignans.11 Isolated by Miyazawa and co-
workers in 1995 from “shin-i”, (-)-magnofargesin (9) is an
antagonist of platelet-activating factor (PAF), which reverses
leukotriene D4-induced bronchoconstriction in guinea pigs
with an LD50 of 19 µM (Scheme 3).12 PAF is a potent
phospholipid activator and mediator of many leukocyte
functions, including platelet aggregation, inflammation, and
anaphylaxis. Antagonists of PAF are of potential therapeutic
value for the treatment of asthma and as protective agents
against ischemic injury.13
Retrosynthetically, we envisioned that, after construction
of the target’s furanoid skeleton from 12, via C-H insertion,
both the C-8 hydroxymethyl group and the right-hand C-8′
“arm” of the lignan system could be installed in a one-pot,
three-component coupling operation (Scheme 3). Specifi-
cally, we anticipated that addition of 2-lithio-1,3-dithiane to
12 would proceed from the less hindered face to generate
an R-sulfonyl anion at C-8′.14 Alkylation of this intermediate
with veratraldehyde would then provide â-hydroxysulfone
11 from which the C7′-C8′ alkene could be installed through
reductive elimination.15
Our route to (()-magnofargesin (9) commenced from
3,4,5-trimethoxybenzyl progargyl ether (13), which was
converted to stannane 12, as previously described (Scheme
4). Sequential exposure of 12 to cyanophenyliodonium triflate
and aqueous sodium benzenesulfinate then provided dihy-
drofuran 11 in 59% yield.16 Although treatment of 11 with
2-lithiodithiane in THF, at -78 °C, now resulted in vinyl
sulfone addition, unexpectedly, attempts to trap the resulting
R-sulfonyl anion with a range of aldehydes, including
veratraldehyde, failed. In all cases, a complex, intractable
mixture of products, which included vinyl sulfone 15, the
product resulting from â-elimination of the conjugate base
of 14, was obtained. The instability of the anionic intermedi-
ate was not entirely unanticipated since Knochel has previ-
ously noted that related 3-phenylsulfonyl tetrahydrofurans
also undergo ring opening upon exposure to n-BuLi.17 Guided
by Craig’s observations of these systems,18 we carried out
the metalation-addition process at -100 °C in anticipation
that the R-sulfonyl anion would be stable at this temperature.
While we believe that deprotonation of 16 occurred under
these conditions, the subsequent reaction with veratraldehyde
proved to be impractically slow. As a result, we opted to
intercept the R-sulfonyl anion by protonation and install the
C8′ side chain in a stepwise fashion. Thus, sequential
(11) Jung, K. Y. N.; Kim, D. S.; Oh, S. R.; Park, S. H.; Lee, I. S.; Lee,
J. J.; Shin, D. H.; Lee, H. K. J. Nat. Prod. 1998, 61, 80 and references
therein.
(12) (a) Miyazawa, M.; Hiroyuki, K.; Kameoka, H. Phytochemistry 1996,
42, 531. (b) Miyazawa, M.; Kasahara, H.; Kameoka, H. Nat. Prod. Lett.
1995, 7, 205. (c) Myazawa, M. Lignan derivative and its use as a
bronchodilator; Japanese Kokai Tokkyo Koho JP 06065224, 1994; Chem.
Abstr. 1994, 121, 91784.
(13) Singh, M.; Saraf, M. K. Drug Future 2001, 26, 883.
(14) (a) Fuchs, P. L.; Braish, T. F. Chem. ReV. 1986, 86, 903. (b) Fuchs,
P. L.; Braish, T. L.; Saddler, J. C. J. Org. Chem. 1988, 53, 3647.
(15) Kocienski, P. J. Reductive Elimination, Vicinal Deoxygenation and
Vicinal Desilylation. In ComprehensiVe Organic Synthesis; Trost, B. M.,
Fleming, I., Eds.; Pergamon: Oxford, UK, 1991; Vol. 6, Chapter 5.2, p
975.
(17) Auvray, P.; Knochel, P.; Normant, J. F. Tetrahedron Lett. 1985,
26, 4455.
(16) This reaction was carried out on scales of up to 8 mmol without
incident.
(18) Craig, D.; Ikin, N. J.; Mathews, N.; Smith, A. M. Tetrahedron 1999,
55, 13471 and other papers in this series.
Org. Lett., Vol. 8, No. 17, 2006
3661